AWM Investment Company, Inc. 13D/13G Filings for OncoCyte Corporation (OCX)

AWM Investment Company, Inc. 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-09
4:06 pm
Purchase		 2025-03-31 13G OncoCyte Corporation
OCX		 AWM Investment Company, Inc. 2,857,069
10.000%		 1,550,760increase
(+118.71%)		 Filing
2025-02-14
2:41 pm
Purchase		 2024-12-31 13G OncoCyte Corporation
OCX		 AWM Investment Company, Inc. 1,306,309
7.500%		 1,306,309increase
(New Position)		 Filing